Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
60,359,615
-
Total 13F shares
-
6,995,274
-
Share change
-
-1,602,866
-
Total reported value
-
$1,411,110
-
Put/Call ratio
-
305%
-
Price per share
-
$0.2019
-
Number of holders
-
27
-
Value change
-
-$885,030
-
Number of buys
-
10
-
Number of sells
-
12
Institutional Holders of Acutus Medical, Inc. - Common Stock, par value $0.001 per share (AFIB) as of Q4 2023
As of 31 Dec 2023 Acutus Medical, Inc. - Common Stock, par value $0.001 per share (AFIB) had 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 6,995,274 shares of stock of the company.
Largest 10 holders included DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), ORBIMED ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, HRT FINANCIAL LP, MILLENNIUM MANAGEMENT LLC, CITADEL ADVISORS LLC, and Virtu Financial LLC.
This table shows 27 institutional shareholders of the security as of 31 Dec 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.